catalyst
as of 2026-07-01Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Sym — primary completion
at a glance
2019-10-16 · Actual — This event happened.
Synthesized from structured facts only — each point cited above.
Event
What
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Sym — primary completion
Type
Trial Readout
Date
2019-10-16
Date type
ACTUAL
Phase
Phase 2
This event happened.
relationships
The graph out of here